Overview

Open-Label Pilot Study to Examine the Value of Substituting Quetiapine for Benzodiazepines

Status:
Terminated
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The hypothesis of this study is that symptoms of anxiety, depression and insomnia; and indices of psychosocial function will all improve, while BZ use will decrease significantly during a twelve-week trial period of substituting quetiapine for benzodiazepines.
Phase:
Phase 4
Details
Lead Sponsor:
Weill Medical College of Cornell University
Collaborator:
AstraZeneca
Treatments:
Quetiapine Fumarate